• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

ECTRIMS 2018 DAILY REPORT – THURSDAY EDITION

October 11, 2018  

ECTRIMS Poster Picks – Thursday, October 11

October 11, 2018  

ECTRIMS 2018 DAILY REPORT – WEDNESDAY EDITION

October 10, 2018  

ECTRIMS Poster Picks – Wednesday, October 10

October 10, 2018  

Laquinimod program cancelled in MS

September 6, 2018  

Heart disease associated with atrophy in MS

August 15, 2018  

Predictors of switching therapies in MS – real-world results

August 1, 2018  

Exploring therapeutic inertia in multiple sclerosis

July 11, 2018  

Update on oral cladribine – Effect on lymphocytes and safety data

May 9, 2018  

MS therapeutics: 1 withdrawal, 1 setback

March 5, 2018  
Previous
21
22
23
24
25
Next

Browse by Topic

  • MS (414)
  • CLINICAL CASES IN MS (16)
  • EPILEPSY (36)
  • BIOMARKERS IN MS (54)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • Library (17)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • DMT prescribing in Canada – survey results posted on June 6, 2025
  • CLINICAL CASES IN MS: A 42 Y.O. WOMAN WITH A SEVERE RELAPSE ON DMF posted on June 2, 2025
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions